Bio-Rad Laboratories (BIO) Curent Deferred Tax Liability (2013 - 2014)
Bio-Rad Laboratories' (BIO) quarterly Curent Deferred Tax Liability came in at $13.8 million in Q2 2014, up 45.49% on a QoQ basis from $9.5 million in Q4 2013.
Bio-Rad Laboratories (BIO) Curent Deferred Tax Liability (2013 - 2014) Analysis & Trends
Bio-Rad Laboratories (BIO) has 2 years of Curent Deferred Tax Liability data on file, last reported at $13.8 million in Q2 2014.
- On a quarterly basis, Curent Deferred Tax Liability changed N/A year-over-year to $13.8 million in Q2 2014; TTM through Jun 2014 was $13.8 million, a N/A change from a year earlier, with the FY2013 full-year figure at $9.5 million, changed N/A from the prior year.
- Curent Deferred Tax Liability for Q2 2014 stood at $13.8 million, up from $9.5 million in the prior quarter.
- Over the last five years, Curent Deferred Tax Liability for BIO reached as high as $13.8 million in Q2 2014 and fell as low as $9.5 million in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Curent Deferred Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Bio-Rad Laboratories | 8.53 Bn | 6.97 Bn | 309.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2014 | 13.76 Mn |
| Jun 30, 2014 | 13.76 Mn |
| Dec 31, 2013 | 9.45 Mn |
| Dec 31, 2013 | 9.45 Mn |